Patents by Inventor Gwendolyn Fyfe

Gwendolyn Fyfe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT WITH ANTI-VEGF ANTIBODIES
    Publication number: 20230218755
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: March 14, 2023
    Publication date: July 13, 2023
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, Robert D. MASS, William NOVOTNY
  • ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20210093715
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human subjects susceptible to or diagnosed with breast cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: May 15, 2020
    Publication date: April 1, 2021
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, See Chun Phan, Xian Zhou
  • TREATMENT WITH ANTI-VEGF ANTIBODIES
    Publication number: 20210015918
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 21, 2021
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, Robert D. MASS, William NOVOTNY
  • TREATMENT WITH ANTI-VEGF ANTIBODIES
    Publication number: 20200171148
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: February 4, 2020
    Publication date: June 4, 2020
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, Robert D. MASS, William NOVOTNY
  • TREATMENT WITH ANTI-VEGF ANTIBODIES
    Publication number: 20190307881
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: June 25, 2019
    Publication date: October 10, 2019
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, Robert D. MASS, William NOVOTNY
  • TREATMENT WITH ANTI-VEGF ANTIBODIES
    Publication number: 20180221473
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: September 14, 2017
    Publication date: August 9, 2018
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, Robert D. MASS, William NOVOTNY
  • Treatment with anti-VEGF antibodies
    Patent number: 9795672
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: October 24, 2017
    Assignee: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, William Novotny
  • ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20170100478
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human subjects susceptible to or diagnosed with breast cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: December 20, 2016
    Publication date: April 13, 2017
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, See Chun Phan, Xian Zhou
  • TREATMENT WITH ANTI-VEGF ANTIBODIES
    Publication number: 20160310592
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: June 30, 2016
    Publication date: October 27, 2016
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, William NOVOTNY
  • TREATMENT WITH ANTI-VEGF ANTIBODIES
    Publication number: 20160304594
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: March 25, 2016
    Publication date: October 20, 2016
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, Robert D. MASS, William NOVOTNY
  • ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20160243227
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human subjects susceptible to or diagnosed with breast cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: May 13, 2016
    Publication date: August 25, 2016
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, See Chun Phan, Xian Zhou
  • TREATMENT WITH ANTI-VEGF ANTIBODIES
    Publication number: 20150359881
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: January 15, 2015
    Publication date: December 17, 2015
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, Robert D. MASS, William NOVOTNY
  • ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20150246124
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human subjects susceptible to or diagnosed with breast cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: May 15, 2015
    Publication date: September 3, 2015
    Applicant: GENENTECH, INC.
    Inventors: Gwendolyn Fyfe, See Chun Phan, Xian Zhou
  • TREATMENT WITH ANTI-VEGF ANTIBODIES
    Publication number: 20140178369
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: December 19, 2013
    Publication date: June 26, 2014
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
  • TREATMENT WITH ANTI-VEGF ANTIBODIES
    Publication number: 20130195847
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: September 4, 2012
    Publication date: August 1, 2013
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
  • TREATMENT WITH ANTI-VEGF ANTIBODIES
    Publication number: 20130028862
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: January 20, 2012
    Publication date: January 31, 2013
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
  • TREATMENT WITH ANTI-VEGF ANTIBODIES
    Publication number: 20110123494
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: February 2, 2011
    Publication date: May 26, 2011
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
  • ADJUVANT CANCER THERAPY
    Publication number: 20100266589
    Abstract: Disclosed herein are methods and compostions comprising anti-VEGF antibodies for use in adjuvant cancer therapy.
    Type: Application
    Filed: April 20, 2010
    Publication date: October 21, 2010
    Inventors: Eric Hedrick, Robert D. Mass, Gwendolyn Fyfe, Norman Wolmark
  • TREATMENT WITH ANTI-VEGF ANTIBODIES
    Publication number: 20100226880
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: October 8, 2009
    Publication date: September 9, 2010
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
  • Anti-Angiogenesis Therapy for the Treatment of Breast Cancer
    Publication number: 20100143351
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human subjects susceptible to or diagnosed with breast cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: November 20, 2009
    Publication date: June 10, 2010
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, See Chun Phan, Xian Zhou